Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2003
08/13/2003CN1117560C Reflux inhibitors
08/12/2003US6605742 Rheumatic diseases; antiarthritic agents; antitumor agents
08/12/2003US6605722 Tyrosine derivatives with anti-leukotrienen activity
08/12/2003US6605641 20-HETE antagonists and agonists
08/12/2003US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
08/12/2003US6605636 Atorvastatin hemi-calcium form VII
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605629 Oxazole derivatives; low toxicity
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605600 Diuretics
08/12/2003US6605593 Enhanced efficacy and reduced toxicity
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605303 Oral pharmaceutical extended release dosage form
08/12/2003US6605276 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/12/2003CA2088702C Aminobenzoic acid derivatives
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064626A2 Double-stranded oligonucleotides
08/07/2003WO2003064625A2 Oligonucleotide compositions with enhanced efficiency
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064472A2 Treatment of ms with goat serum
08/07/2003WO2003064467A1 A complex of a human foxc2 protein and a foxc2-interacting protein
08/07/2003WO2003064456A1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
08/07/2003WO2003064447A2 Immune-modulating peptide
08/07/2003WO2003064443A2 New corticosteroids
08/07/2003WO2003064441A2 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064423A1 Aza-arylpiperazines
08/07/2003WO2003064419A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/07/2003WO2003064418A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
08/07/2003WO2003064417A1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
08/07/2003WO2003064416A1 Heterocyclic tripeptides as hepatitis c inhibitors
08/07/2003WO2003064414A1 Tricyclic compounds useful as angiotensin ii agonists
08/07/2003WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/07/2003WO2003064407A2 Production of δ9 tetrahydrocannabinol
08/07/2003WO2003064404A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064391A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
08/07/2003WO2003064389A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
08/07/2003WO2003064387A2 Substituted indoles as alpha-1 agonists
08/07/2003WO2003064383A2 Phosphorus-containing compounds & uses thereof
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063906A1 Drugs for treating inflammatory diseases
08/07/2003WO2003063905A1 Preventives or remedies for immunological diseases
08/07/2003WO2003063892A1 Use of apelin
08/07/2003WO2003063886A1 Helicobacter pylori adhesion inhibitor
08/07/2003WO2003063884A1 A herbal pharmaceutical composition for treating siriasis and its process
08/07/2003WO2003063875A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063871A1 Phenylpyrimidine amines as ige inhibitors
08/07/2003WO2003063856A1 Jelly preparation containing branched amino acids
08/07/2003WO2003063855A1 Chewable tablet containing branched amino acids
08/07/2003WO2003063854A1 Chewable tablet containing branched amino acids
08/07/2003WO2003063847A1 Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
08/07/2003WO2003063840A2 Transmucosal delivery of proton pump inhibitors
08/07/2003WO2003063800A2 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2003063771A2 N4-acylcytosine nucleosides for treatment of viral iinfections
08/07/2003WO2003063758A2 Bicyclic cb2 cannabinoid receptor ligands
08/07/2003WO2003063573A2 Method for treating diseases with omega interferon
08/07/2003WO2003028662A3 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
08/07/2003WO2002100415A3 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
08/07/2003WO2002068476A3 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
08/07/2003WO2002055541A3 Peptides having inhibiting activity on the production of nitric oxide
08/07/2003WO2002024222A3 Ligands for g protein coupled receptors and methods of using them
08/07/2003WO2002000172A3 Methods for using tetanus toxin for benificial purposes in animals (mammals)
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149277 Triarylimidazole derivatives as cytokine inhibitors
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030149108 Linked biaryl compounds
08/07/2003US20030149107 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
08/07/2003US20030149100 Clear micellized formulations of beta-carotene and method of treating leukoplakia
08/07/2003US20030149094 Compositions comprising ether compounds and pharmaceutical uses therefor
08/07/2003US20030149093 For therapy of dyspepsia, early satiety, bloating and anorexia
08/07/2003US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
08/07/2003US20030149083 For therapy of inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149073 Cycloalkano-indole and -azaindole derivatives
08/07/2003US20030149071 Pyrido [2,1-a] isoquinoline derivatives
08/07/2003US20030149065 Arylkylamine spirofuropyridines useful in therapy
08/07/2003US20030149062 Therapy of inflammatory diseases of the airways or intestines which by administering substances selected from quinazoline derivatives, 4-((3-chloro-4-fluorophenyl)amino)-6-((4-dimethylamino-cyclohexyl)amino) -pyrimido(5,4-d)pyrimidine
08/07/2003US20030149058 Use of dipyridamole or mopidamol for treatment and prevention of fibrin-dependent microcirculation disorders
08/07/2003US20030149056 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/07/2003US20030149051 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, cancer, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149044 Succinic acid salts of 5,7,14-triazatetracyclo[10.1.02.11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
08/07/2003US20030149039 For therapy of disease responsive to antagonist modulation of the Neurokinin-1 (NK-1) receptor in a patient
08/07/2003US20030149037 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
08/07/2003US20030149026 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc.
08/07/2003US20030149018 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/07/2003US20030148985 Methods and reagents for the inhibition of hepatitis B virus replication
08/07/2003US20030148983 Polynucleotide therapy
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148945 Antimicrobial and anti-inflammatory peptides
1 ... 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 ... 1258